Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) ...

The importance of this technique becomes even clearer when considering the larger context. An astonishing 100 million ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Doctors have said access to the drug is a "postcode lottery" as Sky News analysis reveals just 800 people have been ...

This is an audio transcript of the Life and Art from FT Weekend podcast episode: ‘Fashion loves Ozempic. Should we talk about it?’ ...